Communications researcher regrets “severe shortcomings” in three publications

3A communications researcher in Switzerland has made a few errors in his efforts to communicate his research.

Peter J. Schulz, who works at the University of Lugano, has lost a paper which did not “appropriately acknowledge” another paper as its primary source. He has also corrected a paper with “severe shortcomings in the references.” Both papers were published in the journal Argumentation. 

In addition, he is facing allegations that a book chapter contains some unattributed material.

Schultz acknowledged the problems in a statement he emailed to us:

I regret very much the severe shortcomings in the three publications.

Here’s the retraction note for “Comments on ‘Strategic Manoeuvring with the Intention of the Legislator in the Justification of Judicial Decisions’”: Continue reading Communications researcher regrets “severe shortcomings” in three publications

IVF embryo paper pulled for plagiarism, errors, lack of permissions

6A journal is pulling an article (with approval of “most” of the authors) because a similar paper had already been published in Chinese.

That wasn’t the only problem with Aneuploidy analysis of non-pronuclear embryos from IVF with use of array CGH: a case report,” published in the Journal of Molecular Histology. 

The retraction note lists the three things that led to the paper’s retraction:

Continue reading IVF embryo paper pulled for plagiarism, errors, lack of permissions

Four retractions follow Swedish government findings of negligence, dishonesty

242915_1uu_logoA Swedish ethical review board has censured two biologists and their employer, Uppsala University, for events related to “extensive image manipulations” in five papers published between 2010 and 2014. The case has led to criticism from an outside expert — who brought the allegations to Uppsala — over the current system in Sweden for handling such investigations.

Four of the papers have been retracted, and the authors have requested a correction in the fifth.

After an eight-month investigation, in September the government-run Expert Group for Scientific Misconduct at the Central Ethical Review Board in Stockholm, Sweden, concluded that Uppsala professor Kenneth Söderhäll — who has published more than 200 papers — and lecturer Irene Söderhäll acted “negligently” and “dishonestly” by Continue reading Four retractions follow Swedish government findings of negligence, dishonesty

Third retraction appears for Leiden researcher fired in 2013

Screen Shot 2015-12-21 at 12.18.41 PM

A researcher who was fired from Leiden University Medical Center in 2013 for fraud has notched a third retraction, following an investigation by her former workplace.

When Leiden fired Annemie Schuerwegh, they announced two retractions of papers that contained manipulated data. This third retraction — the last, according to a spokesperson for the center  — is for “a discrepancy between the data reported in the article and the original collected data,” per the note.

The 2011 paper, “Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium” published in Arthritis Research & Therapy, suggests the source of a protein involved in rheumatoid arthritis. It has been cited 51 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction note:

Continue reading Third retraction appears for Leiden researcher fired in 2013

Fifth retraction for Wayne State researcher who fudged figures

teresita
Teresita L. Briones

Another retraction has appeared for Teresita Briones, who used to study neuroscience at Wayne State University — the final of five papers flagged by the Office of Research Integrity for containing falsified data.

According to the ORI notice published in May, Briones “intentionally, knowingly, and recklessly engaged in research misconduct by falsifying and/or fabricating data.” This latest paper to be retracted, which looks at the role of specific receptor in chronic inflammation of nervous tissue in rats, has two figures that “were duplicated, reused and falsely relabelled, and claimed to represent different experiments,” according to the retraction note.

The retraction note for “Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling,” published in the Journal of Neuroinflammation, specifies the problematic figures:

Continue reading Fifth retraction for Wayne State researcher who fudged figures

“The peer review process was compromised”: Inflammation drug paper pulled

12

A paper that screened for antibodies that target TNFα, a major source of inflammation, has been retraction after an investigation revealed the peer-review process may have been compromised.

We’ve seen the peer review process “compromised” in a handful of ways — from a mathematician who oversaw the process on several of his own papers, to some 250 papers subject to outright fake peer review. The note for this paper, published in Amino Acids, doesn’t go into details, so we can only wonder what happened in this particular case.

Here’s the note for “Structure‑based development and optimization of therapy antibody drugs against TNFα:”

Continue reading “The peer review process was compromised”: Inflammation drug paper pulled

Authors retract abstract following misconduct by diabetes biotech

1Earlier this year, authors retracted a meeting abstract about a diabetes drug, following the revelation that the biotech that funded the trial committed misconduct.

The retraction was initiated by corresponding author Itamar Raz, at Hadassah Medical Center in Israel. The journal didn’t receive a response from any co-authors who were affiliated with the biotech company, Andromeda, so they were not included in the retraction process.

A few months after Hyperion Therapeutics acquired Andromeda’s diabetes drug DiaPep277, Hyperion announced it had evidence that some employees of Andromeda had “engaged in serious misconduct,” such as using un-blinded data and manipulating the analyses. Two relevant studies on the drug, designed to block the immune response that leads to type 1 diabetes, were retracted last year.

Here’s the retraction note for the abstract “Abstracts of the 50th Annual Meeting of the EASD, Vienna 2014. ‘Evaluation of DiaPep277® treatment in type 1 diabetes by integrated analysis,’” published in the May issue of the journal:

Continue reading Authors retract abstract following misconduct by diabetes biotech

Is an increase in retractions good news? Maybe, suggests new study

SEEIn Latin America, retractions for plagiarism and other issues have increased markedly — which may be a positive sign that editors and authors are paying closer attention to publishing ethics, according to a small study published in Science and Engineering Ethics.

The authors examined two major Latin American/Caribbean databases, which mostly include journals from Brazil, and have been indexing articles for more than 15 years. They found only 31 retractions, all of which appeared in 2008 or later. (Roughly half of the retractions were from journals indexed in the Thomas Reuters’  Journal of Citations Report®  (JCR).)

This was a notable result, the authors write: Continue reading Is an increase in retractions good news? Maybe, suggests new study

Paper claiming extra CO2 doesn’t always lower plant nutrients pulled for errors

11Authors have retracted a large meta-analysis claiming that rising levels of carbon dioxide don’t always reduce nutrients in plants.

After commenters on PubPeer raised concerns, the authors say they found several unintentional errors in their data that could “significantly change conclusions” of the paper in Plant Ecology, according to the retraction note.

The paper found that the impact of rising CO2 depends on many factors — in some cases, extra amounts of this greenhouse gas could actually increase plant nutrients. Trouble is, some of the papers that cited the now-retracted article came to the opposite conclusion: Increased carbon dioxide levels do decrease plant nutrients.

The retraction note for “CO2 effects on plant nutrient concentration depend on plant functional group and available nitrogen: a meta-analysis” explains some of the specifics of the errors, and says that there was “no evidence of bias:”

Continue reading Paper claiming extra CO2 doesn’t always lower plant nutrients pulled for errors

3-D printing paper accidentally includes secrets

9

A paper on 3-D printing has been pulled because it “inadvertently” included some sensitive material.

We’re not sure which parts of the paper were the specific problem. But the sensitive material may have something with how to improve the surfaces of 3-D printed products, which is the subject of “Feasibility of using Copper(II)Oxide for additive manufacturing.”

Here’s what the paper, published in the International Journal of Precision Engineering and Manufacturing contains, according to the abstract:

Additive manufacturing, in spite of its ever wider application range, is still plagued by issues ranging from accuracy to surface finish. In this study, to address the latter issue, the feasibility of using Copper(II)Oxide powder with a polymer binder deposited through a Fused Deposition Modeling (FDM) 3D printing technique is explored.

Here’s the retraction note:

Continue reading 3-D printing paper accidentally includes secrets